Singapore, June 3 -- M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a global life sciences company focused on advancing innovative and sustainable healthcare solutions, have signed a Memorandum of Understanding (MoU) to formalise a strategic, non-exclusive collaboration focused on advancing biopharma localisation, clinical development and next-generation healthcare innovation in Abu Dhabi.

Aligned with the Department of Health - Abu Dhabi's (DoH) efforts to reinforce the Emirate's position as a global hub for life sciences innovation, the collaboration will contribute to the development of an integrated life sciences ecosystem spanning clinical development and innovativ...